Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary 5-ASA excretion in healthy volunteers
NL-OMON36986Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Salcrozine (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Reproducibility and variability of urinary 5-ASA excretion and Urinary 5-ASA adherence cut-off levels. Planned start Nov 2012; status: not yet recruiting.
02
Drugs
Salcrozine
Beyond the preview
Go deeper on NL-OMON36986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36986.